Dennis Langer

Insider Reports History

Entity
Individual
Location
C/O Peter Tsoflias, Blank Rome Llp, One Logan Square, Fl 9, Philadelpha, PA
Signature
/s/ Dennis Langer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dennis Langer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MYRIAD GENETICS INC Director Common Stock 107K $2.04M $19.14 Jun 30, 2022 Direct
Quoin Pharmaceuticals, Ltd. Director Ordinary Shares 53 $38.80 $0.73 Jun 7, 2024 Direct
Brooklyn ImmunoTherapeutics, Inc. Director Stock Option 67K Dec 8, 2021 Direct
Quoin Pharmaceuticals, Ltd. Director Share Option (Right to Buy) 50.7K Dec 9, 2024 Direct
MYRIAD GENETICS INC Director Non-Qualified Stock Option (right to buy) 30K Jun 30, 2022 Direct

Insider Reports Filed by Dennis Langer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNRX Quoin Pharmaceuticals, Ltd. Dec 9, 2024 1 $0 4 Dec 10, 2024 Director
QNRX Quoin Pharmaceuticals, Ltd. Jun 7, 2024 1 -$217 4 Jun 10, 2024 Director
QNRX Quoin Pharmaceuticals, Ltd. Oct 26, 2023 1 $0 4 Oct 30, 2023 Director
QNRX Quoin Pharmaceuticals, Ltd. Jan 1, 2023 0 $0 3/A Mar 7, 2023 Director
MYGN MYRIAD GENETICS INC Jun 30, 2022 0 $0 4 Jun 30, 2022 Director
MYGN MYRIAD GENETICS INC Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
ERNA Brooklyn ImmunoTherapeutics, Inc. Dec 8, 2021 1 $0 4 Dec 10, 2021 Director
MYGN MYRIAD GENETICS INC Aug 3, 2021 3 -$281K 4 Aug 5, 2021 Director
MYGN MYRIAD GENETICS INC Jun 3, 2021 1 $0 4 Jun 4, 2021 Director